{"id":"https://openalex.org/W2026486274","doi":"https://doi.org/10.1593/tlo.12115","title":"Hypoxia Moderates \u03b3134.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures","display_name":"Hypoxia Moderates \u03b3134.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures","publication_year":2012,"publication_date":"2012-06-01","ids":{"openalex":"https://openalex.org/W2026486274","doi":"https://doi.org/10.1593/tlo.12115","mag":"2026486274","pmid":"https://pubmed.ncbi.nlm.nih.gov/22741039","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3384274"},"language":"en","primary_location":{"id":"doi:10.1593/tlo.12115","doi":"https://doi.org/10.1593/tlo.12115","is_oa":true,"landing_page_url":"https://doi.org/10.1593/tlo.12115","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1936523312800088/pdf","source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S1936523312800088/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088548817","display_name":"Gregory K. Friedman","orcid":"https://orcid.org/0000-0002-6653-7420","observed_orcids":["https://orcid.org/0000-0002-6653-7420"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gregory K. Friedman","raw_affiliation_strings":["Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028496643","display_name":"Marilyn C. Haas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marilyn C. Haas","raw_affiliation_strings":["Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Virginia M. Kelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Virginia M. Kelly","raw_affiliation_strings":["Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059491130","display_name":"James M. Markert","orcid":"https://orcid.org/0000-0001-7457-7329","observed_orcids":["https://orcid.org/0000-0001-7457-7329"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M. Markert","raw_affiliation_strings":["Division of Neurosurgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurosurgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014191604","display_name":"G. Yancey Gillespie","orcid":"https://orcid.org/0000-0001-6436-9542","observed_orcids":["https://orcid.org/0000-0001-6436-9542"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Yancey Gillespie","raw_affiliation_strings":["Division of Neurosurgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurosurgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059334176","display_name":"Kevin A. Cassady","orcid":"https://orcid.org/0000-0003-2474-9051","observed_orcids":["https://orcid.org/0000-0003-2474-9051"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin A. Cassady","raw_affiliation_strings":["Division of Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5088548817"],"corresponding_institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":2.0976,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.87437,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"5","issue":"3","first_page":"200","last_page":"207"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.953000009059906},{"id":"https://openalex.org/keywords/oncolytic-herpes-simplex-virus","display_name":"oncolytic herpes simplex virus","score":0.9610000252723694},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-1","display_name":"herpes simplex virus type 1","score":0.5860000252723694},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9629999995231628},{"id":"https://openalex.org/keywords/glioma-stem-cells","display_name":"glioma stem cells","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cd133","display_name":"CD133","score":0.9710000157356262},{"id":"https://openalex.org/keywords/nectin-1","display_name":"nectin-1","score":0.9769999980926514},{"id":"https://openalex.org/keywords/virus-infectivity","display_name":"viral infectivity","score":0.9100000262260437},{"id":"https://openalex.org/keywords/viral-cytotoxicity","display_name":"viral cytotoxicity","score":0.75},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.906000018119812},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6850000023841858},{"id":"https://openalex.org/keywords/oxygen-partial-pressure","display_name":"oxygen partial pressure","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C106358424","wikidata":"https://www.wikidata.org/wiki/Q1662346","display_name":"Infectivity","level":3,"score":0.8228189945220947},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.8146426677703857},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.6898587942123413},{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.6527352929115295},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5743266940116882},{"id":"https://openalex.org/C2993207723","wikidata":"https://www.wikidata.org/wiki/Q4927803","display_name":"Oxygen tension","level":3,"score":0.5683973431587219},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5377120971679688},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.526189386844635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4742516577243805},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4663364887237549},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4202670454978943},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4096095860004425},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.29011887311935425},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2150445580482483},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.08950343728065491},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07504871487617493},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1593/tlo.12115","doi":"https://doi.org/10.1593/tlo.12115","is_oa":true,"landing_page_url":"https://doi.org/10.1593/tlo.12115","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1936523312800088/pdf","source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2387603","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3384274","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3384274","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3384274","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transl Oncol","raw_type":"Text"},{"id":"pmid:22741039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22741039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1593/tlo.12115","doi":"https://doi.org/10.1593/tlo.12115","is_oa":true,"landing_page_url":"https://doi.org/10.1593/tlo.12115","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1936523312800088/pdf","source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1179467038","display_name":"Engineered HSV For Treatment of Malignant Glioma","funder_award_id":"P01CA071933","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4027850796","display_name":"CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS","funder_award_id":"P20CA151129","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7820584853","display_name":"Rheumatic Diseases Core Centers (P30)","funder_award_id":"P30AR048311","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G913463245","display_name":"Molecular Therapeutics for Anaplastic Gliomas","funder_award_id":"P50CA097247","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"},{"id":"https://openalex.org/F4320337844","display_name":"Kaul Pediatric Research Institute","ror":"https://ror.org/01n0pw264"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2026486274.pdf","grobid_xml":"https://content.openalex.org/works/W2026486274.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W1970212185","https://openalex.org/W1970972818","https://openalex.org/W1971977403","https://openalex.org/W1975156886","https://openalex.org/W1976860925","https://openalex.org/W1983217686","https://openalex.org/W1986536654","https://openalex.org/W1988692970","https://openalex.org/W1997221411","https://openalex.org/W2001371234","https://openalex.org/W2005395125","https://openalex.org/W2006276932","https://openalex.org/W2015161652","https://openalex.org/W2023094207","https://openalex.org/W2024265287","https://openalex.org/W2025224982","https://openalex.org/W2026406742","https://openalex.org/W2034490461","https://openalex.org/W2037539566","https://openalex.org/W2043004478","https://openalex.org/W2048043668","https://openalex.org/W2050921603","https://openalex.org/W2051588629","https://openalex.org/W2055145844","https://openalex.org/W2057382033","https://openalex.org/W2060211329","https://openalex.org/W2064622883","https://openalex.org/W2071151466","https://openalex.org/W2079935861","https://openalex.org/W2087211266","https://openalex.org/W2100843222","https://openalex.org/W2101241808","https://openalex.org/W2110711017","https://openalex.org/W2111608713","https://openalex.org/W2125300852","https://openalex.org/W2129428247","https://openalex.org/W2135180965","https://openalex.org/W2143308874","https://openalex.org/W2155105887","https://openalex.org/W2156805103","https://openalex.org/W2156950231","https://openalex.org/W2157441493","https://openalex.org/W2161289668","https://openalex.org/W2169798272","https://openalex.org/W2329898359","https://openalex.org/W4299647924"],"related_works":["https://openalex.org/W2076378079","https://openalex.org/W7099797293","https://openalex.org/W2078828542","https://openalex.org/W2128450583","https://openalex.org/W2050921603","https://openalex.org/W7140498444","https://openalex.org/W2071151466","https://openalex.org/W2941527610","https://openalex.org/W2991541242","https://openalex.org/W2329898359"],"abstract_inverted_index":{"Hypoxia":[0],"plays":[1,139],"a":[2,70,140],"critical":[3],"role":[4,141,223],"in":[5,59,93,116,130,142,147,174,184,205,226],"the":[6,14,82,136,143,177,188,221,227],"tumor":[7,61,160],"microenvironment":[8,228],"of":[9,68,163,176,182,190,216,224,229],"high-grade":[10],"gliomas":[11],"by":[12],"promoting":[13],"glioma":[15],"stem":[16],"cell":[17],"(GSC)-like":[18],"phenotype,":[19],"which":[20],"displays":[21],"resistance":[22],"to":[23,156],"standard":[24],"therapies.":[25],"We":[26],"tested":[27],"three":[28,95,118],"glioblastoma":[29],"multiforme":[30],"xenograft":[31],"lines":[32],"(xenolines)":[33],"against":[34],"\u03b3(1)34.5-deleted":[35],"recombinant":[36],"oncolytic":[37],"herpes":[38],"simplex":[39],"virus":[40],"(oHSV)":[41],"C101":[42,145],"under":[43,91,101,120,203],"1%":[44],"(hypoxia)":[45],"and":[46,57,63,74,107,132,199],"20.8%":[47],"(normoxia)":[48],"oxygen":[49,164],"tension":[50],"for":[51,86,213],"effects":[52],"on":[53],"oHSV":[54,104,157,197,217],"infectivity,":[55,105],"replication,":[56],"cytotoxicity":[58,106,200],"all":[60,94,117],"cells":[62,129,151,161],"CD133(+)":[64,150],"GSCs.":[65],"Expression":[66],"levels":[67],"CD133,":[69],"putative":[71],"GSC":[72],"marker,":[73],"CD111":[75,99],"(nectin-1),":[76],"an":[77],"adhesion":[78],"molecule":[79],"that":[80,135,180,196],"is":[81],"most":[83],"efficient":[84],"method":[85],"HSV":[87],"entry,":[88],"increased":[89,98,173],"significantly":[90],"hypoxia":[92,185,204,225],"xenolines.":[96],"Despite":[97],"expression":[100,168],"hypoxic":[102],"conditions,":[103],"viral":[108,171,192],"recovery":[109],"were":[110,114,152,201],"not":[111,153,187],"improved":[112],"or":[113],"diminished":[115,202],"xenolines":[119,178,208],"hypoxia.":[121,148],"In":[122],"contrast,":[123],"wild-type":[124],"HSV-1":[125],"equally":[126],"infected":[127],"xenoline":[128],"normoxia":[131],"hypoxia,":[133],"suggesting":[134,179],"34.5":[137],"mutation":[138],"decreased":[144,169],"infectivity":[146,198],"Importantly,":[149],"more":[154],"resistant":[155],"than":[158],"CD133(-)":[159],"regardless":[162],"tension.":[165],"Furthermore,":[166],"CD133":[167,183],"as":[170],"dose":[172],"two":[175],"up-regulation":[181],"was":[186],"cause":[189],"reduced":[191],"efficacy.":[193],"Our":[194],"findings":[195],"several":[206],"GBM":[207,230],"likely":[209],"have":[210],"important":[211],"implications":[212],"clinical":[214],"applications":[215],"therapies,":[218],"especially":[219],"considering":[220],"vital":[222],"tumors.":[231]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}